Gaining a foothold: tackling poverty, gender inequality, and HIV in Africa. by Kim, Julia C & Watts, Charlotte H
Kim, JC; Watts, CH (2005) Gaining a foothold: tackling poverty,
gender inequality, and HIV in Africa. BMJ, 331 (7519). pp. 769-72.
ISSN 1468-5833 DOI: 10.1136/bmj.331.7519.769
Downloaded from: http://researchonline.lshtm.ac.uk/12515/
DOI: 10.1136/bmj.331.7519.769
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial
http://creativecommons.org/licenses/by-nc/2.5/
analysis, to which the other authors contributed. ES, SL, and
ADO led the writing of the paper, to which the other authors
contributed. ES and SL are guarantors.
Funding: Funding was provided by the Alliance for Health
Policy and Systems Research (ID-3.115), German Technical
Development (PN: 95.2068.5-001.00), and the European
Commission funded Practihc (pragmatic randomised trials in
health care) project (ICA4-CT-2001-10019). Additional funding
for the study collaborators was provided by the Medical
Research Council of South Africa. The study sponsors approved
the study design but played no part in the collection, analysis,
and interpretation of data; in the writing of the report; or in the
decision to submit the paper for publication.
Competing interests: None declared.
Ethical approval: This study was approved by the Comité
Nacional de Bioética para a Saúde in Mozambique, the Medical
Research Council of Zimbabwe, and the ethics committees of
the London School of Hygiene and Tropical Medicine and
WHO. Written consent was obtained from all respondents
following discussion of the study and provision of an
information sheet.
1 World Health Organization. Commission on Macroeconomics and
Health. Macroeconomics and health: investing in health for economic
development. Geneva, Switzerland: WHO, 2001.
2 Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N. Drug devel-
opment for neglected diseases: a deficient market and a public-health
policy failure. Lancet 2002;359:2188-94.
3 World Health Organization. Priority medicines for Europe and the world.
Geneva, Switzerland: WHO, 2004.
4 Olliaro P, Smith P. The European and developing countries clinical trials
partnership. J HIV Ther 2004;9:53-6.
5 United Nations. United Nations millennium declaration. United Nations
General Assembly resolution 55/2. New York, NY: UN, 2000.
6 Duley L. Maternal mortality and hypertensive disorders of pregnancy in
Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol
1992;99:547-53.
7 World Health Organization. The world health report 2005. Make every
mother and child count. Geneva, Switzerland: WHO, 2005.
8 Duley L, Gülmezoglu A, Henderson-Smart D. Magnesium sulphate and
other anticonvulsants for women with pre-eclampsia. Cochrane Database
Syst Rev 2003(2):CD000025.
9 Eclampsia Trial Collaborative Group. Which anticonvulsant for women
with eclampsia? Evidence from the collaborative eclampsia trial. Lancet
1995;345:1455-63.
10 Magpie Trial Collaborative Group. Do women with pre-eclampsia, and
their babies, benefit from magnesium sulphate? The magpie trial: a ran-
domised placebo-controlled trial. Lancet 2002;359:1877-90.
11 World Health Organization.WHO model list of essential medicines. 13th edn.
Geneva, Switzerland: WHO, 2003.
12 Aaserud M, Lewin S, Innvaer S, Paulsen E, Dahlgren A, Trommald M, et
al. Translating research into policy in developing countries: a case study
of magnesium sulphate for pre-eclampsia. BMC Health Serv Res 2005 (in
press).
13 Sheth S, Chalmers I. Magnesium for preventing and treating eclampsia:
time for international action. Lancet 2002;359:1872-3.
14 WHO/Unicef. Maternal mortality in 2000. Estimates developed by WHO,
Unicef and UNFPA. Geneva, Switzerland: WHO, 2004.
15 Granja A, Machungo F, Gomes A, Bergstrom S, Brabin B. Malaria-related
maternal mortality in urban Mozambique. Ann Trop Med Parasitol
1998;92:257-63.
16 Ministry of Health and Child Welfare. Zimbabwe national health profile
2000. Harare: MoHCW (Epidemiology and Disease Control, National
Health Information and Surveillance Units) in conjunction with the Cen-
tral Statistical Office, 2000.
17 Green J, Thorogood N. Qualitative methods for health research. London:
Sage, 2004.
18 Kaplan WA, Laing R. Paying for pharmaceutical registration in develop-
ing countries. Health Policy Plan 2003;18:237-48.
19 Gravelle H, Rees R. Microeconomics. London: Prentice Hall, 2004.
20 Remarks by Governor John A Kitzhaber. States and provinces: creating
a functional marketplace for prescription drugs, 11-12 Oct 2002,
Portland, Oregon. http://www.oregon.gov/DAS/OHPPR/ORRX/docs/
Governors_Conference_Presentations/Kitzhaber_speech_Drug_Conf_
Oct10_02_Final.pdf (accessed 16 May 2005).
Gaining a foothold: tackling poverty, gender inequality,
and HIV in Africa
Julia C Kim, Charlotte H Watts
Over half of adults infected with HIV in Africa are female—but poverty and social structures still
prevent many women from protecting themselves
The United Nations millennium development goals
have set out specific targets for 2015, including commit-
ments to reduce extreme poverty, increase women’s
empowerment, and reverse the spread of the HIV pan-
demic. In this respect, they clearly recognise what has
been called the triple threat facing Africa: poverty,
gender inequalities, and HIV and AIDS.1 Tackling these
issues is clearly difficult, and many people have greeted
these goals with a sense of scepticism and even futility.
We describe why tackling poverty and gender inequali-
ties is central to controlling the HIV pandemic in Africa
and suggest how it might be achieved.
Women and HIV
Two years ago, the UN secretary general Kofi Annan
declared that “AIDS has a woman’s face.”2 Echoing this
statement, the Joint United Nations Programme on
HIV and AIDS (UNAIDS) has highlighted women,
girls, and HIV and AIDS as the theme for their most
recent World AIDS Day campaign. Today, women
account for nearly half the 40 million people living
with HIV worldwide. In sub-Saharan Africa, 57% of
adults with HIV are women, and young women aged
15 to 24 are more than three times as likely to be
infected as young men.3
Contradictory analyses of Uganda’s success in
tackling HIV and AIDS have sparked debates over the
relative prevention merits of promoting condoms,
sexual fidelity, or abstinence. The United States has
increased its funding for abstinence-only strategies,
while the Catholic Church has questioned the efficacy of
condoms, raising concerns about the influence of
ideological or religious perspectives in shaping global
priorities for prevention.4 Yet a larger question remains.
Regardless of their point of emphasis, why are HIV pre-
vention efforts continuing to fail women and girls?
The prevention messages, whether urging women to
abstain, be faithful, or use condoms, often fail to reflect
the reality of women’s lives and, in particular, the
broader social forces that contribute to their risk. In set-
tings where limited educational or economic opportuni-
ties exist, pressures of poverty lead women and girls to
trade sex for survival.Where women have low status and
financial autonomy, and depend on their partners for
support, abstaining from sex or negotiating use of
condoms are simply not realistic options. Moreover,
physical and sexual violence affect women’s ability to
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protect themselves from infection. Refusing sex,
inquiring about other partners, or suggesting condom
use have all been described as triggers for intimate part-
ner violence; yet all are intimately connected to the
behavioural cornerstones of HIV prevention.5
Although the primary prevention messages remain
important, and access to existing and new female con-
trolled prevention methods, such as the female
condom or microbicides, should be a priority. Yet far
more attention must be devoted to promoting the
wider social and economic interventions that might
reduce women’s vulnerability to HIV. The UN General
Assembly special session on HIV and AIDS made the
gender dimensions of the epidemic explicit. In 2001,
delegates from over 180 countries stressed that gender
equality and the empowerment of women will be criti-
cal in controlling the HIV pandemic.6
How well equipped is the public health community
to respond to this call? Certainly, we have seen some
important successes in decreasing infection rates
among circumscribed groups such as gay men in the
United States or commercial sex workers in Thai-
land.7 8 To date, however, our traditional focus on
health sector interventions and high risk groups has
had limited impact on the generalised epidemics now
facing much of Africa.9
Getting back to basics
In an attempt to expand the scope of intervention
strategies for HIV and AIDS, the concept of
mainstreaming AIDS in development is gaining
currency. The concept seeks to strengthen the ways in
which existing development processes tackle both the
causes and the consequences of HIV and AIDS.10 The
range of actors may be broad, reaching beyond the
health sector to include the judiciary, government min-
istries, industry, and non-governmental organisations.
In relation to women’s empowerment, mainstreaming
HIV challenges sectors to examine how their core
activities address the status of women and, in so doing,
their risk of HIV infection.
For example, when a woman’s right to own, inherit,
and control property is limited by customary or statu-
tory laws, the potential role of legal reforms as a part of
a comprehensive response to HIV cannot be ignored.
In South Africa, the Customary Marriages Act now
mandates that a woman no longer becomes the prop-
erty of her husband’s family when he dies, thus
safeguarding her independence and entitlement to
household assets. Similarly, in Kenya, the government
has recently pledged to promote gender equality,
creating a ministry of gender and a new constitution
protecting women’s property rights. Although not
explicitly linked to HIV and AIDS, such systematic
efforts to increase women’s economic, social, and
political empowerment must be supported as key
components of a comprehensive AIDS strategy.11
Microfinance initiatives
By improving access to credit and savings services,
microfinance initiatives seek to provide business skills
and income generating opportunities for poor women
who are excluded from formal financial services and
markets. In 1998, the Microcredit Summit Campaign
reported reaching 2.1 million impoverished African
families. The most recent report notes that by 2003,
microfinance initiatives had reached an estimated 6.4
million clients in Africa, showing a potential to reduce
household poverty and improve security of livelihood
among people in extreme poverty.12 Though far from
being a solution to poverty, such programmes can
enable some of the most vulnerable women to “at least
gain a foothold on the bottom rung,” from which they
might begin to progress.13
Alongside the economic benefits, such initiatives
may enhance autonomy among participants. The newly
acquired economic and business skills translate into
improvements in self esteem and self confidence, larger
social networks, and wider control over household deci-
sion making.14 Moreover, evaluations of programmes
such as the Grameen Bank and Bangladesh Rural
Advancement Committee have shown an increase in
acceptance and use of contraceptives, suggesting that
women who contribute money and participate in family
decisions have more control over sexual and reproduc-
tive health decisions.15 16 Such programmes have also
shown a potential to reduce the incidence of domestic
violence, primarily by channelling resources through
women, organising women into solidarity groups, and
making women’s lives more public.17
A foothold but not the whole ladder
At the same time, it is important to acknowledge that
the links between microfinance and empowerment are
complex. Some researchers have pointed out that
although targeting women for microfinance has been
promoted as a means for both increasing cost
efficiency (because women have higher repayment
rates) and more effective alleviation of poverty
(because they prioritise expenditure on family welfare),
channelling resources to women may have the
potential to exacerbate gender related tensions in the
household. Others have suggested that mobilising a
critical mass of participants and shifting social norms
may be necessary before domestic violence is reduced
and women are more broadly empowered.17 18
There is also increasing recognition that empower-
ing individuals requires strengthening access to
Women in an intervention for AIDS and gender equity programme in
South Africa used disposable cameras to help them “think gender”
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resources and building individuals’ ability to use those
resources, make decisions, and take leadership. Hence,
some authors have suggested that adding a training or
capacity building component to the financial aspect of
microfinance programmes may be important in
catalysing the broader benefits of increased access to
economic resources19 20 and potentially diminishing
the risk of gender related conflict.17 21
Microfinance initiatives in countries such as
Uganda, Rwanda, Ghana, Togo, Zambia, Zimbabwe,
and South Africa are starting to include education
about HIV as part of the programme.22 23 The
approach can be successful even in areas with a high
prevalence of HIV, where households receiving loans
are facing HIV related illness and death. In Uganda, for
example, the Foundation for International Community
Assistance has recovered 100% of its loans while
simultaneously working to promote condoms and
educate its clients about safer sex.24
Broadening the scope of interventions
Many opportunities may exist for integrating HIV and
gender issues into broader development strategies. In
Kenya, an intervention that provided female sex work-
ers with education on fertility and HIV and AIDS
alongside business training and start-up funds has led
to reductions in the numbers of sexual partners and
increases in condom use.25 In Zimbabwe, the Rusape
Girls Empowerment Village is attempting to
strengthen the development of disadvantaged rural
girls by combining HIV education with increased
access to information and communication technology
through a village computer laboratory.26 Such broad
interventions have the potential to generate multiple
benefits. The Tostan development programme in Sen-
egal began with the aim of improving literacy and
awareness of human rights among women, and ended
up mobilising communities around women’s repro-
ductive health and rights, including public declarations
against female genital cutting in 31 villages.27
Greater documentation and evaluation of such
approaches is needed. A few initiatives are beginning
to explore the impact of “structural level interventions”
that aim to influence the economic or social contexts in
which risk occurs. In rural South Africa we are using a
cluster randomised design to explore the effect on bio-
logical and behavioural outcomes relating to HIV and
AIDS and violence against women of a programme
that combines microfinance with training on gender
issues, HIV, and violence.22 28
Where do we begin?
Attempting to tackle immense and complex issues
such as poverty and gender inequality may seem over-
whelming. Yet there are signs that global leaders may
be finally recognising the need to couple resources for
AIDS specific interventions and technologies with
explicit commitments aimed at reducing poverty.29 At
the same time, there is a need to develop and test prac-
tical intervention strategies that acknowledge the
importance of addressing women’s economic and
social empowerment, while mainstreaming AIDS
within these broader development goals.
The programmatic approaches we have described
suggest an important entry point for tackling HIV in
the context of the immediate realities that women
face. At the same time, however, they need to intersect
with macro level influences that carry the potential for
far more sustained and systemic changes in women’s
status and wellbeing. Too often, the impact of
scaling-up or replicating locally successful models
continues to be constrained by a lack of articulation
and engagement with broader structures and forces.
How might the wider benefits of microfinance
programmes be influenced, by the effect of global
agricultural and trade policies on rural livelihoods or
the role of multinational corporations in shaping
women’s access to labour markets? Ultimately,
intervention strategies need to be linked to the
broader globalisation processes that condition and
constrain local possibilities.30
This year has been declared the UN international
year of microcredit. To date, the campaign seems to be
on track with its goal of reaching 100 million of the
world’s poorest families by the end of the year, offering
much needed encouragement in meeting the chal-
lenge of the millennium development goals.12 We wait
for world leaders to couple rhetoric with action and
take substantial steps to ensure trade justice, cancel
poor countries’ unpayable debts, and increase aid to
the current target of 0.7% of their national income. In
the meantime, those working on the ground will
continue to show up every morning, despite the dire
statistics, in pursuit of that most precious commodity
needed for Africa and the international community—
hope.
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Summary points
Current strategies to change HIV risk behaviour
continue to fail women and girls in Africa
Structural interventions that aim to increase
women’s economic, social, and political
empowerment are key components of a
comprehensive AIDS strategy
Economic development initiatives (such as
microfinance) may present a strategic entry point
for addressing the relations between HIV, poverty,
and gender inequality
Ultimately, such local, programmatic approaches
need to intersect with national and international
polices to produce systemic changes in women’s
status and wellbeing
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Patients’ readiness to start highly active antiretroviral
treatment for HIV
Hirut T Gebrekristos, Koleka P Mlisana, Quarraisha Abdool Karim
Assessing whether patients are ready to start antiretroviral treatment may improve HIV prevention
and treatment outcomes
Initiatives to increase access to antiretroviral treatment
in resource constrained settings are growing, but the
scale and magnitude of the HIV epidemic in these set-
tings raises a number of operational and ethical
challenges.Most people infected with HIV are unaware
of their status, and people who are aware of their status
fear stigmatisation and discrimination. Key themes
about access to treatment include who gets treatment,
when is the best time to start treatment, and how to
ensure therapeutic success.
Numerous guidelines for treatment have been
developed nationally and internationally. One concern
is how initiation of antiretroviral treatment should relate
to patients’ readiness and commitment. Although
patients’ readiness is emphasised as a requirement for
starting treatment in several guidelines,1–4 the guidelines
are neither clear nor in consensus about what
constitutes readiness and how this readiness should be
assessed. Given this ambiguity, readiness may be used to
ration resources, particularly in resource poor settings,
in which access to antiretrovirals is currently gaining
support. The potential of using readiness to improve
HIV prevention and care outcomes, however, mandates
that we closely examine the use of readiness for starting
highly active antiretroviral treatment (HAART).
Studies about assessing patients’ readiness for
starting HAART or the impact of this on therapeutic
success are few. One small study found that lack of
readiness resulted in interrupted treatment and risky
sexual behaviour; therefore, readiness for treatment
may help care givers to make decisions about when to
start treatment with antiretrovirals for each patient.5
The potential importance of treatment readiness for
therapeutic success is why a more structured and
systematic approach to evaluating readiness is needed.
In addition, a systematic evaluation of the use of treat-
ment readiness becomes particularly important in set-
tings where “readiness” may be misused to ration
resources. Rigorously collected data will be critical in
shaping appropriate interventions that go beyond
anecdotal notions that readiness is important in deter-
mining when to start HAART.
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